000 01427 a2200385 4500
005 20250512205010.0
264 0 _c19821203
008 198212s 0 0 eng d
022 _a0014-4827
024 7 _a10.1016/0014-4827(82)90078-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWu, J S
245 0 0 _aInhibition of dihydrofolate reductase gene expression following serum withdrawal or db-cAMP addition in methotrexate-resistant mouse fibroblasts.
_h[electronic resource]
260 _bExperimental cell research
_cSep 1982
300 _a159-69 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aBlood
650 0 4 _aBucladesine
_xpharmacology
650 0 4 _aCell Line
650 0 4 _aDNA
_xbiosynthesis
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aInterphase
650 0 4 _aKinetics
650 0 4 _aMethotrexate
_xpharmacology
650 0 4 _aMice
650 0 4 _aPolyribosomes
_xanalysis
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aTetrahydrofolate Dehydrogenase
_xbiosynthesis
650 0 4 _aTheophylline
_xpharmacology
700 1 _aWiedemann, L M
700 1 _aJohnson, L F
773 0 _tExperimental cell research
_gvol. 141
_gno. 1
_gp. 159-69
856 4 0 _uhttps://doi.org/10.1016/0014-4827(82)90078-7
_zAvailable from publisher's website
999 _c6288351
_d6288351